Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Clinical Investigation

• Publication date

  2015-02-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI78421PMID 25574843PMCID PMC4319412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: the need of larger datasets.

  2014cited by this paper
• Primary age-related tauopathy (PART): a common pathology associated with human aging

  2014cited by this paper
• Alteration of the microRNA network during the progression of Alzheimer's disease

  2013cited by this paper
• MicroRNAs and neurodegeneration: role and impact.

  2013cited by this paper
• Exploiting Drosophila genetics to understand microRNA function and regulation.

  2012cited by this paper
• The MAPT H1 haplotype is associated with tangle-predominant dementia

  2012cited by this paper
• MicroRNAs in neuronal function and dysfunction.

  2012cited by this paper
• RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries.

  2011cited by this paper
• The Power and Richness of Modelling Tauopathies in Drosophila

  2011cited by this paper
• Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter

  2011cited by this paper
• Ancient animal microRNAs and the evolution of tissue identity

  2010cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms

  2009cited by this paper
• Next generation software for functional trend analysis

  2009cited by this paper
• Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

  2008cited by this paper
• Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

  2004cited by this paper
• Micro-RNAs

  2002cited by this paper
• Gene expression pattern Identification and characterization of the Drosophila tau homolog

  2001cited by this paper
• Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells

  1988cited by this paper
• Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors

  1985cited by this paper
• Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

  1976cited by this paper

• Epigenetic Changes in Alzheimer’s Disease and Interventions for Therapy

  2026cites this paper
• Non-coding RNAs in the pathogenesis of Alzheimer’s disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation

  2025cites this paper
• MicroRNA-based recent research developments in Alzheimer's disease

  2025cites this paper
• Epigenetics Modulators as Therapeutics for Neurological Disorders.

  2025cites this paper
• Staufen2 dysregulation in neurodegenerative disease

  2025cites this paper
• An Update on Neuroaging on Earth and in Spaceflight

  2025cites this paper
• MicroRNAs modulation by curcumin, catalpol, and other natural products in Alzheimer’s disease: a review

  2025cites this paper
• PEARL: Integrative multi-omics classification and omics feature discovery via deep graph learning

  2025cites this paper
• Direct and indirect role of non-coding RNAs in company with amyloid and tau protein in promoting neuroinflammation in post-ischemic brain neurodegeneration

  2025cites this paper
• Prolonged Survival with Dieting for Improved Autophagy

  2025cites this paper
• Insights From a Scoping Review and Bibliometric Analysis of Trends and Advances in Biomarker Research: The Role of MicroRNAs in Cognitive Decline Across Neurodegenerative Diseases

  2025cites this paper
• Regulation of miR-219 and its target RalGPS dictates acute synaptic plasticity at the Drosophila neuromuscular junction

  2025cites this paper
• MicroRNAs and Synapse Turnover in Alzheimer's Disease.

  2024cites this paper
• MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review

  2024cites this paper
• Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions

  2024cites this paper
• Scutellarin Attenuates Microglia Activation in LPS‐Induced BV‐2 Microglia via miRNA‐7036a/MAPT/PRKCG/ERK Axis

  2024cites this paper
• REGULATORY ROLES OF microRNAs IN MODULATING MITOCHONDRIAL DYNAMICS, AMYLOID BETA FIBRILLATION, MICROGLIAL ACTIVATION, AND CHOLINERGIC SIGNALING: IMPLICATIONS FOR ALZHEIMER'S DISEASE PATHOGENESIS.

  2024cites this paper
• miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages.

  2024cites this paper
• Cerebellar Micro-RNA Profile in a Mouse Model of Spinocerebellar Ataxia Type 2

  2024cites this paper
• The Dual Role of the 16mer Motif Within the 3′ Untranslated Region of the Variant Surface Glycoprotein of Trypanosoma brucei

  2024cites this paper
• Potential mechanisms of non-coding RNA regulation in Alzheimer’s disease

  2024cites this paper
• Therapeutic potential and microRNA regulating properties of phytochemicals in Alzheimer’s disease

  2024cites this paper
• MicroRNA-219 in the central nervous system: a potential theranostic approach

  2024cites this paper
• The emerging roles of particulate matter-changed non-coding RNAs in the pathogenesis of Alzheimer's disease: A comprehensive in silico analysis and review.

  2024cites this paper
• The regulation of miRNAs using curcumin and other polyphenols during the prevention and treatment of Alzheimer's disease.

  2024cites this paper
• Hypermethylation and downregulation of microRNA219a-2 activates the ALDH1L2/GSH/PAI-1 pathway for fibronectin degradation in renal fibrosis.

  2024cites this paper
• Molecular subtypes of ALS are associated with differences in patient prognosis

  2023cites this paper
• Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease.

  2023cites this paper
• MIRit: an integrative R framework for the identification of impaired miRNA-mRNA regulatory networks in complex diseases

  2023cites this paper
• miRNA as an Ultimate and Emerging Diagnostic Approach for the Detection of Alzheimer's Disease.

  2023cites this paper
• Reappraisal of the Concept of Accelerated Aging in Neurodegeneration and Beyond

  2023cites this paper
• Multi-layered transcriptomic analysis reveals a pivotal role of FMR1 and other developmental genes in Alzheimer's disease-associated brain ceRNA network

  2023cites this paper
• A New Perspective for the Treatment of Alzheimer’s Disease: Exosome-like Liposomes to Deliver Natural Compounds and RNA Therapies

  2023cites this paper
• Roles of Non-Coding RNA in Alzheimer’s Disease Pathophysiology

  2023cites this paper
• Dysregulated miRNA and mRNA Expression Affect Overlapping Pathways in a Huntington’s Disease Model

  2023cites this paper
• Understanding the multifaceted role of miRNAs in Alzheimer’s disease pathology

  2023cites this paper
• Hypermethylation suppresses microRNA-219a-2 to activate the ALDH1L2/GSH/PAI-1 pathway for fibronectin degradation in renal fibrosis

  2023cites this paper
• Epigenetic regulons in Alzheimer's disease.

  2023cites this paper
• MiRNA-219a-1-3p inhibits the malignant progression of gastric cancer and is regulated by DNA methylation

  2023cites this paper
• MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease

  2023cites this paper
• MicroRNAs as Possible Biomarkers for Diagnosis and Therapy of Alzheimer’s Disease by Regulating the Abnormal Expression of Genes Related to Tau

  2023cites this paper
• Editorial Special Issue Neuroscience "Tauopathies".

  2023cites this paper
• Non-Coding RNAs as Key Players in the Neurodegenerative diseases: Multi-platform Strategies and Approaches for exploring the Genome's Dark Matter.

  2023cites this paper
• Glutathione targeted tragacanthic acid-chitosan as a non-viral vector for brain delivery of miRNA-219a-5P: An in vitro/in vivo study.

  2022cites this paper
• primiReference: a reference for analysis of primary-microRNA expression in single-nucleus sequencing data.

  2022cites this paper
• RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation

  2022cites this paper
• Posttranscriptional regulation of neurofilament proteins and tau in health and disease

  2022cites this paper
• Retromer deficiency in Tauopathy models enhances the truncation and toxicity of Tau

  2022cites this paper
• Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases

  2022cites this paper
• Perspectives on Mechanisms Supporting Neuronal Polarity From Small Animals to Humans

  2022cites this paper
• Admixture Mapping of Alzheimer’s disease in Caribbean Hispanics identifies a new locus on 22q13.1

  2022cites this paper
• Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

  2022cites this paper
• New Advances in Exosome-based Targeted Drug Delivery Systems.

  2022cites this paper
• Differential expression of serum extracellular vesicle microRNAs and analysis of target-gene pathways in major depressive disorder

  2022cites this paper
• In silico Analysis of Polymorphisms in microRNAs Deregulated in Alzheimer Disease

  2021cites this paper
• A Review on the Correlation between the Pathology of Alzheimer's Disease and microRNA

  2021cites this paper
• Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer’s Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling

  2021cites this paper
• Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm

  2021cites this paper
• Engineering extracellular vesicles for Alzheimer's disease: An emerging cell-free approach for earlier diagnosis and treatment.

  2021cites this paper
• Free radical biology in neurological manifestations: mechanisms to therapeutics interventions

  2021cites this paper
• RNA Modifications in Neurodegenerations

  2021cites this paper
• Extracellular vesicles derived from inflammation-educated stem cells reverse brain inflammation- Implication of miRNAs Alternative: MicroRNAs in Extracellular Vesicles of Educated Stem Cells Attenuate Brain Inflammation.

  2021cites this paper
• The Contribution of Epigenetic Inheritance Processes on Age-Related Cognitive Decline and Alzheimer’s Disease

  2021cites this paper
• SPOROS: A pipeline to analyze DISE/6mer seed toxicity

  2021cites this paper
• The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers

  2021cites this paper
• Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead

  2021cites this paper
• The Potential Neuroprotective Role of Free and Encapsulated Quercetin Mediated by miRNA against Neurological Diseases

  2021cites this paper
• Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer’s Disease Using Post-mortem Brain Tissue Samples

  2021cites this paper
• MicroRNA 219-5p inhibits alveolarization by reducing platelet derived growth factor receptor-alpha

  2021cites this paper
• Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer’s Disease Using Bioinformatic Analyses

  2021cites this paper
• Epigenetics of Alzheimer’s Disease

  2021cites this paper
• MicroRNA‐219a‐5p−mediated inhibition of CaMKIIγ facilitates vestibular compensation in acute vertigo by promoting protein kinase C expression

  2020cites this paper
• A Day in the Life: Identification of Developmentally Regulated MicroRNAs in the Colorado Potato Beetle (Leptinotarsa decemlineata; Coleoptera: Chrysomelidae)

  2020cites this paper
• Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.

  2020cites this paper
• Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease

  2020cites this paper
• Extracellular RNA in human health and disease

  2020cites this paper
• Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

  2020cites this paper
• Epigenetic Basis of Lead-Induced Neurological Disorders

  2020cites this paper
• Regulatory noncoding RNAs and the major histocompatibility complex.

  2020cites this paper
• Exosomes: Their Role in Pathogenesis, Diagnosis and Treatment of Diseases

  2020cites this paper
• Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease

  2020cites this paper
• Transcriptomics in Alzheimer’s Disease: Aspects and Challenges

  2020cites this paper
• Genome-wide profiling and predicted significance of post-mortem brain microRNA in Alzheimer's disease.

  2020cites this paper
• Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease

  2020cites this paper
• miR-149-5p inhibition reduces Alzheimer's disease β-amyloid generation in 293/APPsw cells by upregulating H4K16ac via KAT8

  2020cites this paper
• Advances and Challenges in Understanding MicroRNA Function in Tauopathies: A Case Study of miR-132/212

  2020cites this paper
• MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development

  2020cites this paper
• miR ‐ 149 ‐ 5 p inhibition reduces Alzheimer ' s disease β ‐ amyloid generation in 293 / APPsw cells by upregulating H 4 K 16 ac via KAT 8

  2020cites this paper
• MicroRNAs Modulate the Pathogenesis of Alzheimer’s Disease: An In Silico Analysis in the Human Brain

  2020influential citation
• Hippocampal and cortical tissue-specific epigenetic clocks indicate an increased epigenetic age in a mouse model for Alzheimer’s disease

  2020cites this paper
• A Systematic Review of Current Progresses in The Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer's disease.

  2020cites this paper
• Implication of microRNAs in Alzheimer's disease pathogenesis

  2020cites this paper
• MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers

  2020cites this paper
• Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease

  2020cites this paper
• Dietary Advanced Glycation end Products Induced Cognitive Impairment in Aged ICR Mice: Protective Role of Quercetin.

  2019cites this paper
• MiR‐219 represses expression of dFMR1 in Drosophila melanogaster

  2019cites this paper
• Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease

  2019cites this paper
• The Potential Role of Dysregulated miRNAs in Alzheimer’s Disease Pathogenesis and Progression

  2019cites this paper
• miR-3099 promotes neurogenesis and inhibits astrogliogenesis during murine neural development.

  2019cites this paper
• A Drosophila model of neuronal ceroid lipofuscinosis CLN4 reveals a hypermorphic gain of function mechanism

  2019cites this paper